A phase 1, Randomised, placebo-controlled, single-blind, single-ascending dose study, to determine the safety and tolerability of intravenous Gemini in healthy volunteers.
100 项与 Revelation Biosciences Sub, Inc. 相关的临床结果
0 项与 Revelation Biosciences Sub, Inc. 相关的专利(医药)
100 项与 Revelation Biosciences Sub, Inc. 相关的药物交易
100 项与 Revelation Biosciences Sub, Inc. 相关的转化医学